755 filings
Page 7 of 38
4
du Toit Michael
21 Jun 21
AERIE PHARMACEUTICALS / Toit Michael du ownership change
4:18pm
4
Cagle Gerald D.
21 Jun 21
AERIE PHARMACEUTICALS / Gerald D. Cagle ownership change
4:15pm
4
McDonnell Peter J
21 Jun 21
AERIE PHARMACEUTICALS / Peter J McDonnell ownership change
4:13pm
4
Croarkin Richard
21 Jun 21
AERIE PHARMACEUTICALS / Richard Croarkin ownership change
4:11pm
8-K
AERI
Aerie Pharmaceuticals Inc
21 Jun 21
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
AERI
Aerie Pharmaceuticals Inc
21 Jun 21
Regulation FD Disclosure
4:02pm
8-K
AERI
Aerie Pharmaceuticals Inc
17 Jun 21
Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan
6:36am
8-K
AERI
Aerie Pharmaceuticals Inc
25 May 21
Regulation FD Disclosure
6:32am
8-K
AERI
Aerie Pharmaceuticals Inc
24 May 21
Departure of Directors or Certain Officers
5:25pm
8-K
AERI
Aerie Pharmaceuticals Inc
20 May 21
Regulation FD Disclosure
6:30am
8-K
AERI
Aerie Pharmaceuticals Inc
12 May 21
Regulation FD Disclosure
6:36am
10-Q
2021 Q1
AERI
Aerie Pharmaceuticals Inc
Quarterly report
6 May 21
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
5 May 21
Aerie Pharmaceuticals Reports First Quarter 2021
4:03pm
8-K
AERI
Aerie Pharmaceuticals Inc
29 Apr 21
Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease
6:40am
8-K
AERI
Aerie Pharmaceuticals Inc
28 Apr 21
Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
6:40am
DEFA14A
AERI
Aerie Pharmaceuticals Inc
27 Apr 21
Additional proxy soliciting materials
4:16pm
DEF 14A
AERI
Aerie Pharmaceuticals Inc
Definitive proxy
27 Apr 21
4:05pm
8-K
AERI
Aerie Pharmaceuticals Inc
19 Apr 21
Regulation FD Disclosure
6:41am
8-K
AERI
Aerie Pharmaceuticals Inc
14 Apr 21
Regulation FD Disclosure
6:31am
8-K
AERI
Aerie Pharmaceuticals Inc
30 Mar 21
Regulation FD Disclosure
8:05am